Lifecore Biomedical, Inc. (LFCR): Free Cash Flow
-$13.62M
Year ended 2025-05-25
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-05-25 | -$13.62M | n/m | 2025-08-07, From 2024-05-27 |
| 2024-05-26 | -$18.14M | n/c | 2025-08-07, From 2023-05-29 |
| No annual figure between 2022-05-29 and 2024-05-26. | |||
| 2022-05-29 | -$48.82M | n/m | 2024-08-26, From 2021-05-31 |
| 2021-05-30 | -$2.79M | n/c | 2024-03-20, From 2020-06-01 |
| 2020-05-31 | -$29.25M | n/m | 2023-03-16, From 2019-05-27 |
| 2019-05-26 | -$28.71M | n/m | 2021-07-29, From 2018-05-28 |
| 2018-05-27 | -$13.81M | n/m | 2020-08-14, From 2017-05-29 |
| 2017-05-28 | $6.83M | n/m | 2019-08-01, From 2016-05-30 |
| 2016-05-29 | -$18.93M | n/c | 2018-08-09, From 2015-06-01 |
| No annual figure between 2013-05-26 and 2016-05-29. | |||
| 2013-05-26 | $12.35M | -26.5% | 2015-07-31, From 2012-05-28 |
| 2012-05-27 | $16.81M | +115.9% | 2014-08-01, From 2011-05-30 |
| 2011-05-29 | $7.79M | +239.8% | 2013-08-07, From 2010-05-31 |
| 2010-05-30 | $2.29M | n/a | 2012-08-08, From 2009-06-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$13.62M | n/m |
| Xencor Inc (XNCR) | 2025-12-31 | -$138.27M | n/m |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | -$180.0K | n/m |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$75.37M | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $22.82M | +291.4% |
| Macrogenics Inc (MGNX) | 2025-12-31 | -$82.95M | n/m |
| UroGen Pharma Ltd. (URGN) | 2025-12-31 | -$162.73M | n/m |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $238.50M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$27.91M | n/m |
Compare LFCR, XNCR, GYRE, KPTI side by side · Screen every company in Pharmaceutical Preparations ↗